Overview

• 130,000 square feet Corporate Headquarters
• 57,000 square feet of manufacturing, packaging, and warehouse
• Recently completed 5,500 square feet warehouse expansion includes additional schedule CII vault & CIII cage space
• 17,000 square feet of laboratory space for product development and analytical testing
• 56,000 square feet of employee, office and mechanical space

Capabilities

• Rx solutions, suspensions, topicals, tablets, capsules, and powder for suspension
• DEA-licensed for Schedule II controlled substances

Capacity

• Solid Dose ~1.2 billion doses/yr
• Liquids ~53 million bottles/yr
• Liquid Unit Dose ~23 million doses/yr
• Powder ~12 million bottles/yr

Overview

• 47,000 square feet Containment Facility
• 32,000 square feet of manufacturing, packaging, and warehouse
• 100 nano-gram per eight-hour time weighted average maximum exposure limit to ensure employee safety
• Low-humidity suite for processing and encapsulating moisture-sensitive compounds
• 15,000 square feet of employee, office and mechanical space

Capabilities

• Fully-contained high potency facility with capabilities to manufacture hormone, steroid, and oncolytic products
• DEA Schedule III capability

Capacity

• Tablets ~2.5 billion doses/yr
• Capsules ~150 million doses/yr
• Liquids ~3 million bottles/yr
• Topicals ~2 million tubes/yr